MedTrace Logo

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

NCT03532971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-05-22

No results posted yet for this study

Summary

This research study is evaluating the reactivation of BK virus in patients who have undergone allogeneic hematopoietic-cell transplantation.

Conditions

  • BK Virus Infection

Interventions

OTHER

Symptom index questionnaire

A survey administered to identify the symptoms of the patient

DIAGNOSTIC_TEST

BK polyomavirus PCR

quantitative PCR testing

OTHER

quality of life questionnaires

Standard questionnaires validated for HCT recipients

Sponsors & Collaborators

Principal Investigators

  • Jerome Ritz, MD · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2020-09-14
Completion
2020-09-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532971 on ClinicalTrials.gov